Drug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany. Hormosan Pharma GmbH, a wholly-owned subsidiary of the company in Germany, has introduced Luforbec in the European nation, Lupin said in a statement.
